Section Arrow
ANIK.NASDAQ
- Anika Therapeutics
Quotes are at least 15-min delayed:2026/11/14 14:25 EST
Regular Hours
Last
 13.4
-0.41 (-2.97%)
Day High 
13.97 
Prev. Close
13.81 
1-M High
21.85 
Volume 
87.85K 
Bid
13.2
Ask
20
Day Low
13.255 
Open
13.89 
1-M Low
13.3301 
Market Cap 
184.99M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 16.99 
20-SMA 18.98 
50-SMA 19.81 
52-W High 22.88 
52-W Low 9.0101 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.13/0.95
Enterprise Value
209.19M
Balance Sheet
Book Value Per Share
10.27
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
112.82M
Operating Revenue Per Share
12.19
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AKANAkanda Corp.1.36+0.6883+102.47%-- 
HLNHaleon plc9.17+0.08+0.88%18.97PE
HIMSHims & Hers Health19.73------ 
TEVATeva Pharmaceutical Industries Limited44.5+0.85+1.95%102.3PE
VTRSViatris20.82+0.15+0.73%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.